Johnson & Johnson is scheduled to release its Q2 earnings results on July 15, 2026, with analysts forecasting earnings of $2.85 per share and $25.05 billion in revenue. The company's stock rose 3.6% ahead of the announcement. Additionally, Zacks reports indicate that JNJ is among the companies poised to beat earnings estimates in their upcoming quarterly reports.
Analysts forecast JNJ earnings of $2.85 per share on $25.02 billion in revenue, as the healthcare giant enters its Q2 report with strong year-to-date momentum.
Read the full storyZacks reports suggest JNJ and CBOE are poised to beat quarterly estimates, driven by favorable analyst revisions and historical surprise trends.
Analysts expect JNJ to report EPS of $2.85 and revenue of $25.05 billion in its upcoming financial report scheduled for release on July 15.